🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial tests the feasibility and utility of a biology guided t...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2026-12-19
Trial ID
NCT07590583
The Neutrophil to Lymphocyte Ratio (NLR) is a frequently used biomarker of ...
Status
Completed
Location
Centro di Riferimento Oncologico di Aviano (CRO), IRCCS
Start Date
2019-10-31
Trial ID
NCT04172220
Treatments Being Tested
This study is being conducted in patients with newly diagnosed breast cance...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2012-10
Trial ID
NCT01847001
The Core Gel Study is designed to demonstrate safety and effectiveness of M...
Status
Completed
Location
Mentor Worldwide, LLC
Start Date
2000-09
Trial ID
NCT00753922
Treatments Being Tested
The purpose of this study is to compare the effects of aerobic exercise tra...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2013-01
Trial ID
NCT01943695
Treatments Being Tested
This is an open-label, two-part, phase 1-2 dose-finding study designed to d...
Status
Active Not Recruiting
Location
University of California, San Francisco
Start Date
2020-07-01
Trial ID
NCT04478279
Treatments Being Tested
Gene expression, the transfer of the genetic code into cellular proteins is...
Status
Unknown
Location
Maidstone and Tunbridge Wells NHS Trust
Start Date
2019-05-05
Trial ID
NCT03430024
Treatments Being Tested
ACTIVE is a prospective, single-arm, phase I/IIa study examining an active ...
Status
Recruiting
Location
University of Pittsburgh Medical Center
Start Date
2025-11-01
Trial ID
NCT07262138
Treatments Being Tested
This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Status
Unknown
Location
Cancer institute
Start Date
2016-12
Trial ID
NCT03123770
Treatments Being Tested
A total of 93 suitable patients will be randomly allocated into three group...
Status
Unknown
Location
Hany Mohamed Elgohary
Start Date
2023-04-15
Trial ID
NCT05920369